The Motley Fool

Key Data Points

Primary metrics and data points about Geron Corp.
Current Price: $2.98
Prev Close: $3.04
Open: $3.03
Bid: $2.96
Ask: $2.97
Day's Range: $2.89 - $3.09
52wk Range: $1.76 - $4.67
Volume: 1,345,116
Avg Vol 3,540,279
Market Cap: $471M
P/E (ttm): -12.67
EPS (ttm): ($0.24)
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Geron Corp.

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

GERN vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Geron Corp.
CAPS Rating 3 out of 5
639 Outperform
60 Underperform
CAPS All Stars
93 Outperform
18 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John A. Scarlett, CEO

100% Approve

Based on 2 Ratings

More Details for GeronJobs

Powered by

More Details about Geron Corp

Primary metrics and data points about Geron Corp.